Skip to main content
Top
Published in: Clinical Rheumatology 9/2017

01-09-2017 | Original Article

Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative

Authors: Grace H. Lo, Timothy E. McAlindon, Jeffrey N. Katz, Jeffrey B. Driban, Lori Lyn Price, Charles B. Eaton, Nancy J. Petersen, Christie M. Ballantyne, Maria E. Suarez-Almazor

Published in: Clinical Rheumatology | Issue 9/2017

Login to get access

Abstract

We evaluated the relationship of systolic blood pressure, diastolic blood pressure, pulse pressure, and treatment with antihypertensives with knee osteoarthritis incidence in a US cohort. We performed a longitudinal study (2004–2010) nested within the Osteoarthritis Initiative Study including only individuals without knee osteoarthritis at baseline. Systolic blood pressure, diastolic blood pressure, and pulse pressure were assessed at baseline, 12-, 24-, and 36-month visits. Knee radiographs at baseline, 12-, 24-, 36- and 48-month visits defined radiographic osteoarthritis, Kellgren and Lawrence grade ≥2. We performed logistic regression, adjusting for age, sex, body mass index, NSAID use, number of antihypertensive medications, diabetic medications, and cholesterol medications. One thousand nine hundred and thirty people (6040 observations) were included. Annual incidence rates of radiographic osteoarthritis by systolic blood pressure quartiles (lowest to highest) were 2.1, 3.4, 3.7, and 3.7%. Fully adjusted odds ratios of incident radiographic osteoarthritis (OA) for the 2nd-4th quartiles were 1.6, 1.7, and 1.6 relative to the lowest quartile (p for trend = 0.03). Pulse pressure results were similar. There was no association with diastolic blood pressure. Compared to those not taking any antihypertensive medications, those taking ≥3 had decreased odds (0.4, 0.1–1.0) of developing incident OA. In a US cohort, higher systolic blood pressure and pulse pressure are associated with increased incidence of radiographic knee osteoarthritis while treatment with ≥3 antihypertensive medications was associated with reduced incidence. These findings suggest a new and promising avenue for research on disease modification in knee osteoarthritis.
Literature
1.
go back to reference Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG (2016) Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res (Hoboken) 68(5):574–580CrossRef Cisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG (2016) Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population-based survey. Arthritis Care Res (Hoboken) 68(5):574–580CrossRef
2.
go back to reference Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA (2009) Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum 60(12):3546–3553CrossRefPubMed Kotlarz H, Gunnarsson CL, Fang H, Rizzo JA (2009) Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum 60(12):3546–3553CrossRefPubMed
3.
go back to reference Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, Kelly-Hayes M, Wolf PA, Kreger BE, Kannel WB (1994) The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 84(3):351–358CrossRefPubMedPubMedCentral Guccione AA, Felson DT, Anderson JJ, Anthony JM, Zhang Y, Wilson PW, Kelly-Hayes M, Wolf PA, Kreger BE, Kannel WB (1994) The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health 84(3):351–358CrossRefPubMedPubMedCentral
4.
go back to reference Mankin HJ (1993) Clinical features of osteoarthritis. In: Kelly WN, EDJ H, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 4th edn. W.B. Saunders Co., Philadelphia, pp 1374–1384 Mankin HJ (1993) Clinical features of osteoarthritis. In: Kelly WN, EDJ H, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 4th edn. W.B. Saunders Co., Philadelphia, pp 1374–1384
7.
go back to reference Robertsson O, Bizjajeva S, Fenstad AM, Furnes O, Lidgren L, Mehnert F, Odgaard A, Pedersen AB, Havelin LI (2010) Knee arthroplasty in Denmark, Norway and Sweden. A pilot study from the Nordic Arthroplasty Register Association. Acta Orthop 81(1):82–89CrossRefPubMedPubMedCentral Robertsson O, Bizjajeva S, Fenstad AM, Furnes O, Lidgren L, Mehnert F, Odgaard A, Pedersen AB, Havelin LI (2010) Knee arthroplasty in Denmark, Norway and Sweden. A pilot study from the Nordic Arthroplasty Register Association. Acta Orthop 81(1):82–89CrossRefPubMedPubMedCentral
10.
go back to reference Larmer PJ, Reay ND, Aubert ER, Kersten P (2013) A systematic review of guidelines for the physical management of osteoarthritis. Arch Phys Med Rehabil Larmer PJ, Reay ND, Aubert ER, Kersten P (2013) A systematic review of guidelines for the physical management of osteoarthritis. Arch Phys Med Rehabil
11.
go back to reference Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, Beavers DP, Hunter DJ, Lyles MF, Eckstein F et al (2013) Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA 310(12):1263–1273CrossRefPubMedPubMedCentral Messier SP, Mihalko SL, Legault C, Miller GD, Nicklas BJ, DeVita P, Beavers DP, Hunter DJ, Lyles MF, Eckstein F et al (2013) Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA 310(12):1263–1273CrossRefPubMedPubMedCentral
12.
go back to reference Towheed TE, Hochberg MC (1997) A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Semin Arthritis Rheum 26(5):755–770CrossRefPubMed Towheed TE, Hochberg MC (1997) A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Semin Arthritis Rheum 26(5):755–770CrossRefPubMed
13.
go back to reference Nilsdotter AK, Toksvig-Larsen S, Roos EM (2009) Knee arthroplasty: are patients’ expectations fulfilled? A prospective study of pain and function in 102 patients with 5-year follow-up. Acta Orthop 80(1):55–61CrossRefPubMedPubMedCentral Nilsdotter AK, Toksvig-Larsen S, Roos EM (2009) Knee arthroplasty: are patients’ expectations fulfilled? A prospective study of pain and function in 102 patients with 5-year follow-up. Acta Orthop 80(1):55–61CrossRefPubMedPubMedCentral
14.
go back to reference Yoshimura N, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, Akune T (2012) Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthr Cartil 20(11):1217–1226CrossRefPubMed Yoshimura N, Muraki S, Oka H, Tanaka S, Kawaguchi H, Nakamura K, Akune T (2012) Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthr Cartil 20(11):1217–1226CrossRefPubMed
15.
go back to reference Wallace SM, Yasmin, McEniery CM, Maki-Petaja KM, Booth AD, Cockcroft JR, Wilkinson IB (2007) Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 50(1):228–233CrossRefPubMed Wallace SM, Yasmin, McEniery CM, Maki-Petaja KM, Booth AD, Cockcroft JR, Wilkinson IB (2007) Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 50(1):228–233CrossRefPubMed
16.
go back to reference Washburn RA, Smith KW, Jette AM, Janney CA (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46(2):153–162CrossRefPubMed Washburn RA, Smith KW, Jette AM, Janney CA (1993) The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol 46(2):153–162CrossRefPubMed
17.
go back to reference Crentsil V, Ricks MO, Xue QL, Fried LP (2010) A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 8(3):215–224CrossRefPubMed Crentsil V, Ricks MO, Xue QL, Fried LP (2010) A pharmacoepidemiologic study of community-dwelling, disabled older women: factors associated with medication use. Am J Geriatr Pharmacother 8(3):215–224CrossRefPubMed
18.
go back to reference Wanke LA (1977) Self-instructional guide to the Iowa Drug Information Service. Drug Intell Clin Pharm 11(11):688–689CrossRefPubMed Wanke LA (1977) Self-instructional guide to the Iowa Drug Information Service. Drug Intell Clin Pharm 11(11):688–689CrossRefPubMed
20.
go back to reference Altman RD, Gold GE (2007) Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr Cartil 15(Suppl A):A1–56CrossRefPubMed Altman RD, Gold GE (2007) Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthr Cartil 15(Suppl A):A1–56CrossRefPubMed
21.
go back to reference Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159–174CrossRefPubMed
23.
go back to reference Zhang Y, Glynn RJ, Felson DT (1996) Musculoskeletal disease research: should we analyze the joint or the person? J Rheumatol 23(7):1130–1134PubMed Zhang Y, Glynn RJ, Felson DT (1996) Musculoskeletal disease research: should we analyze the joint or the person? J Rheumatol 23(7):1130–1134PubMed
24.
go back to reference Cochran WG (1954) Some methods of strengthening the common χ2 tests. Biometrics 10:417–451CrossRef Cochran WG (1954) Some methods of strengthening the common χ2 tests. Biometrics 10:417–451CrossRef
25.
go back to reference Armitage P (1955) Tests for linear trends in proportions and frequencies. Biometrics 11:375–386CrossRef Armitage P (1955) Tests for linear trends in proportions and frequencies. Biometrics 11:375–386CrossRef
26.
go back to reference Marks R, Allegrante JP (2002) Comorbid disease profiles of adults with end-stage hip osteoarthritis. Med Sci Monit 8(4):CR305–CR309PubMed Marks R, Allegrante JP (2002) Comorbid disease profiles of adults with end-stage hip osteoarthritis. Med Sci Monit 8(4):CR305–CR309PubMed
27.
go back to reference Weinberger M, Tierney WM, Booher P (1989) Common problems experienced by adults with osteoarthritis. Arthritis Care Res 2(3):94–100CrossRefPubMed Weinberger M, Tierney WM, Booher P (1989) Common problems experienced by adults with osteoarthritis. Arthritis Care Res 2(3):94–100CrossRefPubMed
28.
go back to reference Pope JE, Anderson JJ, Felson DT (1993) A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 153(4):477-84 Pope JE, Anderson JJ, Felson DT (1993) A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 153(4):477-84
29.
go back to reference Johnson AG, Nguyen TV, Day RO. Do (1994) nonsteroidal anti-inflammatory drugs affect blood pressure? A metaanalysis. Ann Intern Med 121(4):289-300 Johnson AG, Nguyen TV, Day RO. Do (1994) nonsteroidal anti-inflammatory drugs affect blood pressure? A metaanalysis. Ann Intern Med 121(4):289-300
30.
go back to reference Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290(2):199–206CrossRefPubMed Hajjar I, Kotchen TA (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290(2):199–206CrossRefPubMed
31.
go back to reference Wilking SV, Belanger A, Kannel WB, D’Agostino RB, Steel K (1988) Determinants of isolated systolic hypertension. JAMA 260(23):3451–3455CrossRefPubMed Wilking SV, Belanger A, Kannel WB, D’Agostino RB, Steel K (1988) Determinants of isolated systolic hypertension. JAMA 260(23):3451–3455CrossRefPubMed
32.
go back to reference Mitchell GF, Conlin PR, Dunlap ME, Lacourciere Y, Arnold JM, Ogilvie RI, Neutel J, Izzo JL Jr, Pfeffer MA (2008) Aortic diameter, wall stiffness, and wave reflection in systolic hypertension. Hypertension 51(1):105–111CrossRefPubMed Mitchell GF, Conlin PR, Dunlap ME, Lacourciere Y, Arnold JM, Ogilvie RI, Neutel J, Izzo JL Jr, Pfeffer MA (2008) Aortic diameter, wall stiffness, and wave reflection in systolic hypertension. Hypertension 51(1):105–111CrossRefPubMed
33.
go back to reference Antikainen R, Jousilahti P, Tuomilehto J (1998) Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens 16(5):577–583CrossRefPubMed Antikainen R, Jousilahti P, Tuomilehto J (1998) Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population. J Hypertens 16(5):577–583CrossRefPubMed
34.
go back to reference Xing D, Xu Y, Liu Q, Ke Y, Wang B, Li Z, Lin J (2016) Osteoarthritis and all-cause mortality in worldwide populations: grading the evidence from a meta-analysis. Sci Rep 6:24393CrossRefPubMedPubMedCentral Xing D, Xu Y, Liu Q, Ke Y, Wang B, Li Z, Lin J (2016) Osteoarthritis and all-cause mortality in worldwide populations: grading the evidence from a meta-analysis. Sci Rep 6:24393CrossRefPubMedPubMedCentral
35.
go back to reference Liu R, Kwok WY, Vliet Vlieland TP, Kroon HM, Meulenbelt I, Houwing-Duistermaat JJ, Rosendaal FR, Huizinga TW, Kloppenburg M (2015) Mortality in osteoarthritis patients. Scand J Rheumatol 44(1):70–73CrossRefPubMed Liu R, Kwok WY, Vliet Vlieland TP, Kroon HM, Meulenbelt I, Houwing-Duistermaat JJ, Rosendaal FR, Huizinga TW, Kloppenburg M (2015) Mortality in osteoarthritis patients. Scand J Rheumatol 44(1):70–73CrossRefPubMed
36.
go back to reference Cerhan JR, Wallace RB, El-Khoury GY, Moore TE, Long CR (1995) Decreased survival with increasing prevalence of full-body, radiographically defined osteoarthritis in women. Am J Epidemiol 141(3):225–234CrossRefPubMed Cerhan JR, Wallace RB, El-Khoury GY, Moore TE, Long CR (1995) Decreased survival with increasing prevalence of full-body, radiographically defined osteoarthritis in women. Am J Epidemiol 141(3):225–234CrossRefPubMed
37.
go back to reference Ravi B, Croxford R, Austin PC, Lipscombe L, Bierman AS, Harvey PJ, Hawker GA (2014) The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis: propensity score matched landmark analysis. Br J Sports Med 48(21):1580CrossRefPubMed Ravi B, Croxford R, Austin PC, Lipscombe L, Bierman AS, Harvey PJ, Hawker GA (2014) The relation between total joint arthroplasty and risk for serious cardiovascular events in patients with moderate-severe osteoarthritis: propensity score matched landmark analysis. Br J Sports Med 48(21):1580CrossRefPubMed
38.
go back to reference Findlay DM (2007) Vascular pathology and osteoarthritis. Rheumatology (Oxford) 46(12):1763–1768CrossRef Findlay DM (2007) Vascular pathology and osteoarthritis. Rheumatology (Oxford) 46(12):1763–1768CrossRef
39.
go back to reference Hussain SM, Wang Y, Shaw JE, Magliano DJ, Wong TY, Wluka AE, Graves S, Tapp RJ, Cicuttini FM (2015) Retinal arteriolar narrowing and incidence of knee replacement for osteoarthritis: a prospective cohort study. Osteoarthr Cartil 23(4):589–593CrossRefPubMed Hussain SM, Wang Y, Shaw JE, Magliano DJ, Wong TY, Wluka AE, Graves S, Tapp RJ, Cicuttini FM (2015) Retinal arteriolar narrowing and incidence of knee replacement for osteoarthritis: a prospective cohort study. Osteoarthr Cartil 23(4):589–593CrossRefPubMed
40.
go back to reference Gossec L, Paternotte S, Bingham CO 3rd, Clegg DO, Coste P, Conaghan PG, Davis AM, Giacovelli G, Gunther KP, Hawker G et al (2011) OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol 38(8):1765–1769CrossRefPubMedPubMedCentral Gossec L, Paternotte S, Bingham CO 3rd, Clegg DO, Coste P, Conaghan PG, Davis AM, Giacovelli G, Gunther KP, Hawker G et al (2011) OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol 38(8):1765–1769CrossRefPubMedPubMedCentral
41.
go back to reference Clockaerts S, Van Osch GJ, Bastiaansen-Jenniskens YM, Verhaar JA, Van Glabbeek F, Van Meurs JB, Kerkhof HJ, Hofman A, Stricker BH, Bierma-Zeinstra SM (2012) Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis 71(5):642–647CrossRefPubMed Clockaerts S, Van Osch GJ, Bastiaansen-Jenniskens YM, Verhaar JA, Van Glabbeek F, Van Meurs JB, Kerkhof HJ, Hofman A, Stricker BH, Bierma-Zeinstra SM (2012) Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis 71(5):642–647CrossRefPubMed
42.
go back to reference Kadam UT, Blagojevic M, Belcher J (2013) Statin use and clinical osteoarthritis in the general population: a longitudinal study. J Gen Intern Med 28(7):943–949CrossRefPubMedPubMedCentral Kadam UT, Blagojevic M, Belcher J (2013) Statin use and clinical osteoarthritis in the general population: a longitudinal study. J Gen Intern Med 28(7):943–949CrossRefPubMedPubMedCentral
43.
go back to reference Gierman LM, Kuhnast S, Koudijs A, Pieterman EJ, Kloppenburg M, van Osch GJ, Stojanovic-Susulic V, Huizinga TW, Princen HM, Zuurmond AM (2013) Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice—a translational model for atherosclerosis. Ann Rheum Dis Gierman LM, Kuhnast S, Koudijs A, Pieterman EJ, Kloppenburg M, van Osch GJ, Stojanovic-Susulic V, Huizinga TW, Princen HM, Zuurmond AM (2013) Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice—a translational model for atherosclerosis. Ann Rheum Dis
44.
go back to reference Williams MF, London DA, Husni EM, Navaneethan S, Kashyap SR (2016) Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complicat 30(5):944–950CrossRefPubMed Williams MF, London DA, Husni EM, Navaneethan S, Kashyap SR (2016) Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complicat 30(5):944–950CrossRefPubMed
Metadata
Title
Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis Initiative
Authors
Grace H. Lo
Timothy E. McAlindon
Jeffrey N. Katz
Jeffrey B. Driban
Lori Lyn Price
Charles B. Eaton
Nancy J. Petersen
Christie M. Ballantyne
Maria E. Suarez-Almazor
Publication date
01-09-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3656-z

Other articles of this Issue 9/2017

Clinical Rheumatology 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.